Mylan Recalls Clonazepam Tablets Due to Impurity Specification Failure
Mylan Institutional, Inc. is recalling Clonazepam Tablets, 0.5 mg, because a known impurity exceeded specifications at the 6-month timepoint.
- Product
- Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21
- Category
- Drug
- Distribution
- Distributed nationwide